The launch of Ontario’s vehicle innovation network signals readiness for next-generation auto solutions, Alberta invests tens of millions of dollars to fund vaccine research and manufacturing capacity, research activity continues to grow at colleges and institutes across Canada, and more.
Organization: Merck Canada
The Short Report – April 28, 2021: COVID-19 data portal goes live, Protein Industries Canada launches new phase of plant-based food plan, Carleton funding bolsters ecosystem conservation, and more
Genome Canada’s portal for tracking variants of concern across Canada is up and running; a Carleton biology team gets support for bolstering ecosystem conservation; Protein Industries Canada starts the second phase of plans to boost plant-based foods, feed and ingredients; a briefing from the Royal Society of Canada calls on federal leadership to stabilize the postsecondary sector; and more.
CATALIS welcomes new partners
The CATALIS Quebec Clinical Trials initiative has announced new public partners and industry funding as it moves closer to its goal of doubling private sector investment in the province’s early stage clinical trials (ESCT) and providing patients early access to innovative healthcare.
Three CECRs receive $4 million from Merck Canada
Merck Canada is investing $4 million in three Centres of Excellence for Commercialization and Research (CECR) as part of a $100-million commitment it made in 2010 when it closed its Merck Frosst Centre for Therapeutic Research in a global restructuring (R$, July 19/10). The funding goes to the Institute for Research in Immunology and Cancer…
Merck invests in $12.5 million in three research institutions
Merck Canada is investing $12.5 million in three Montreal-based university- and hospital-affiliated research institutions as part of its $100-million commitment to the province, announced when it decided to shutter the Merck Frosst Centre for Therapeutic Research (R$, July 19/10). The funding will be invested in the McGill University Health Centre, the University of Montreal Hospital…
Merck commits $5 million to Quebec’s CQDM
Merck Canada is investing a further $5 million over five years in the Quebec Consortium for Drug Discovery (CQDM), a not-for-profit organization of which Merck is a founding member (R$, June 20/08). The investment is part of a 2010 pledge Merck made to support Quebec-based R&D, which coincided with its decision to shutter its Merck…